Exocrine pancreatic insufficiency (EPI) is diagnosed primarily through a stool test that measures levels of an enzyme called elastase. This test is the recommended first step because it’s noninvasive, widely available, and doesn’t require you to stop eating or follow a special diet beforehand. But the diagnosis isn’t always straightforward, and depending on your results and symptoms, your doctor may use additional tests or imaging to confirm what’s going on.
The Fecal Elastase Test: First-Line Screening
Elastase is a digestive enzyme your pancreas produces. When your pancreas is functioning normally, elastase passes through your digestive tract without breaking down, so measuring it in a stool sample gives a reliable snapshot of how well your pancreas is working. The American Gastroenterological Association recommends fecal elastase as the most appropriate initial test for EPI.
Results fall into three ranges:
- Above 200 mcg/g: Normal. This effectively rules out EPI in most people.
- 100 to 200 mcg/g: Indeterminate. You may or may not have EPI, and further testing is typically needed.
- Below 100 mcg/g: Strong evidence of EPI.
One important detail: the stool sample must be solid or semi-solid. Watery or diluted samples can artificially lower elastase levels, triggering a false positive. If you’re having severe diarrhea at the time of testing, the result may not be accurate. The test also carries a high false-positive rate in people who have a low baseline probability of EPI, such as those with diarrhea-predominant irritable bowel syndrome. A low elastase number in someone without clear risk factors doesn’t automatically mean EPI.
If you’re currently taking pancreatic enzyme supplements, you may need to stop them for five days before the test so they don’t interfere with results. Don’t stop any medication without checking with your provider first.
The 72-Hour Fecal Fat Test
This older test directly measures how much fat your body fails to absorb. You eat 100 grams of fat per day for three days while collecting all stool produced during that window. A result of more than 7 grams of fat per day (or more than 21 grams total over 72 hours) confirms fat malabsorption.
The test is highly accurate, but it’s cumbersome. Collecting stool for three straight days while sticking to a precise high-fat diet makes it unpopular with both patients and clinicians. It’s used less frequently now that fecal elastase testing is available, but it remains useful when elastase results are borderline or when a doctor needs objective proof of malabsorption.
Direct Pancreatic Function Testing
The most accurate way to diagnose EPI is a direct pancreatic function test, sometimes called an endoscopic pancreatic function test. During this procedure, a hormone called secretin is injected into your bloodstream. Secretin signals your pancreas to release digestive fluid rich in bicarbonate. A thin tube passed through your mouth collects fluid samples from the upper part of your small intestine.
If the peak bicarbonate concentration in any sample is 80 mmol/L or higher, your pancreas is functioning normally. Anything below that threshold is considered abnormal. This test is the gold standard for detecting EPI, especially mild cases that fecal elastase might miss. The downside is that it requires endoscopy, is only available at specialized centers, and takes more time and preparation than a simple stool test.
Breath Testing as an Alternative
A carbon-13 mixed triglyceride breath test offers a noninvasive middle ground. You swallow a meal containing a specially labeled fat. If your pancreas produces enough enzymes, your body digests the fat and releases carbon-13, which shows up in your breath. Low levels of carbon-13 in exhaled air suggest your pancreas isn’t breaking down fat properly.
A pooled analysis of six studies found this breath test has a sensitivity of 84% and specificity of 87% for diagnosing EPI. That means it correctly identifies most people who have the condition and correctly clears most people who don’t, though it’s not quite as definitive as direct function testing. It’s not yet widely available everywhere but is gaining traction as a practical option.
What Imaging Can and Can’t Tell You
CT scans and MRIs don’t diagnose EPI directly, but they can reveal structural damage to the pancreas that makes EPI likely. In people with chronic pancreatitis, certain imaging findings strongly correlate with low elastase levels. About 79% of patients with moderate to severe widening of the main pancreatic duct had low elastase, and 86% of those with pancreatic tissue thinning (atrophy) had the same. Calcifications scattered throughout the pancreas, enlarged side branches of the pancreatic duct, and stones lodged inside the duct all tracked closely with impaired function.
Patients with low elastase had noticeably thinner pancreatic tissue (averaging about 12 mm) compared to those with normal function (about 17 mm). Their main pancreatic duct was roughly twice as wide. These structural changes help explain why the pancreas can no longer produce enough enzymes, and they give doctors confidence in the diagnosis when combined with abnormal test results.
Imaging alone isn’t enough to confirm EPI because some people have structural damage without significant enzyme deficiency, and others have EPI without obvious changes on a scan. It works best as a complementary piece of the puzzle.
Ruling Out Conditions That Mimic EPI
Chronic diarrhea, bloating, and greasy stools can come from several conditions besides EPI, and telling them apart matters because the treatments are completely different. The diagnostic workup typically follows a structured approach that looks at stool characteristics first: large-volume, fatty, foul-smelling stools point more toward malabsorption, while smaller-volume stools with mucus or blood suggest an inflammatory or functional cause.
Certain red flags push the evaluation beyond basic testing. These include unexplained weight loss, diarrhea that wakes you at night, symptoms that started recently in someone over 50, a family history of gastrointestinal disease, blood in the stool, or unexplained iron deficiency. Any of these warrants a more thorough investigation.
Risk factors also guide diagnosis. If you’ve had gallbladder removal, gastric bypass surgery, radiation therapy to the abdomen, or a history of heavy alcohol use or pancreatitis, EPI becomes more plausible. Without these risk factors, conditions like celiac disease, small intestinal bacterial overgrowth, or inflammatory bowel disease are more likely culprits. Initial lab work often includes celiac antibody testing, markers of intestinal inflammation, and screening for certain infections to narrow things down before landing on EPI as the explanation.
How Diagnosis Typically Unfolds
For most people, the process starts with symptoms (persistent diarrhea, oily or floating stools, bloating, unintended weight loss) and a fecal elastase test. If your elastase is clearly below 100, the diagnosis is relatively straightforward, especially if you have known risk factors like chronic pancreatitis or a history of pancreatic surgery. Your doctor will likely start enzyme replacement therapy and see if your symptoms improve, which itself serves as a form of confirmation.
If results land in the gray zone between 100 and 200, or if the stool sample quality was questionable, you may be asked to repeat the test or move on to a fecal fat collection or breath test. In cases where the clinical picture still doesn’t add up, a direct pancreatic function test or detailed imaging may be needed to settle the question. The path from first symptom to clear diagnosis can take some patience, but the combination of stool testing, clinical history, and imaging gives doctors a reliable toolkit to work with.